Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.9983
Delayed Data
As of 9:55am ET
 -0.0016 / -0.16%
Today’s Change
0.82
Today|||52-Week Range
1.57
-20.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues19.3M1.3M18.1M19.0M
 
 
 
 
 
Depreciation And Amortization2.5M3.8M6.2M9.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses125.8M93.4M50.6M17.5M
 
 
 
 
 
Research And Development91.4M68.5M38.3M12.9M
 
 
 
 
 
Total Operating Expenses128.3M97.2M56.8M27.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-109.0M-95.9M-38.7M-8.1M
 
 
 
 
 
Extraordinary Credit0.000.00--6.4M
 
 
Extraordinary Charge-2.6M-8.1M-11.7M-4.4M
 
 
 
 
 
Interest Expense On Debt3.5M3.1M2.4M2.3M
 
 
 
 
 
Other Expenses247.0K-23.0K66.0K-6.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-114.4M-107.0M-52.7M-15.0M
 
 
 
 
 
Net Income-114.4M-107.0M-52.7M-15.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.4M50.9M52.3M55.7M
 
 
 
 
 
Shares To Calculate EPS Diluted43.4M50.9M52.3M55.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.64-$2.10-$1.01-$0.27
 
 
 
 
 
EPS Diluted-$2.64-$2.10-$1.01-$0.27